The Mcs7 quantitative trait locus is associated with an increased susceptibility to mammary cancer in congenic rats and an allele-specific imbalance

Oncogene

Volumn 25, Issue 36, 2006, Pages 5011-5017

  Cotroneo, M S ^a   Merry, G M ^a   Haag, J D ^a   Lan, H ^a   Shepel, L A ^a   Gould, M N ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Animal models; Breast cancer; Genotype phenotype correlation; Loss of heterozygosity (LOH)

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; GENOMIC DNA;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER SUSCEPTIBILITY; CHROMOSOME 10; CONGENIC STRAIN; GENETIC LINKAGE; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY LOSS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT;

ALLELES; ANIMALS; BASE SEQUENCE; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; LOSS OF HETEROZYGOSITY; MAMMARY NEOPLASMS, EXPERIMENTAL; QUANTITATIVE TRAIT LOCI; RATS; RATS, WISTAR;

RODENTIA;

EID: 33747369218     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209506     Document Type: Article

References (32)

1. Bargmann CI, Hung MC, Weinberg RA. (1986). Nature 319: 226-230.
2. Callahan R, Cropp C, Sheng ZM, Merlo G, Steeg P, Liscia D et al. (1993). J Cell Biochem Suppl 17G: 167-172.
3. Chen K-S, Shepel LA, Haag JD, Heil GM, Gould MN. (1996). Carcinogenesis 17: 1561-1566.
4. Dumitrescu RG, Cotarla I. (2005). J Cell Mol Med 9: 208-221.
5. Easton DF. (1999). Breast Cancer Res 1: 14-17.
6. Haag JD, Brasic GM, Shepel LA, Newton MA, Grubbs CJ, Lubet RA et al. (1999). Mol Carcinog 24: 47-56.
7. Haag JD, Hsu L-C, Newton MA, Gould MN. (1996). Mol Carcinog 17: 134-143.
8. Haag JD, Shepel LA, Kolman BD, Monson DM, Benton ME, Watts KT et al. (2003). Cancer Res 63: 5808-5812.
9. Hino O, Majima S, Kobayashi T, Honda S, Momose S, Kikuchi Y et al. (2001). Mut Res 477: 155-164.
10. Kindler-Röhrborn A, Koelsch BU, Fischer C, Held S, Rajewsky MF. (1999). Cancer Res 59: 1109-1114.
11. Knudson AG. (1971). Proc Natl Acad Sci USA 68: 820-823.
12. Koelsch BU, Kindler-Röhrborn A, Held S, Zabel S, Rajewsky MF. (2002). Carcinogenesis 23: 1033-1037.
13. Lan H, Kendziorski CM, Haag JD, Shepel LA, Newton MA, Gould MN. (2001). Genetics 157: 331-339.
14. Lan H, Shepel LA, Haag JD, Gould MN. (1999). Mamm Genome 10: 687-691.
15. Lasko D, Cavenee W, Nordenskjold M. (1991). Ann Rev Genet 25: 281-314.
16. Lastowska M, Chung Y-J, Cheng Ching N, Haber M, Norris MD, Kees UR et al. (2004). Genes Chrom Cancer 40: 158-163.
17. Lastowska M, Cotterill S, Brown N, Cullinane C, Variend S, Lunec J et al. (2002). Genes Chrom Cancer 34: 428-436.
18. Lesueur F, Pharoah PD, Laing S, Ahmed S, Jordan C, Smith PL et al. (2005). Hum Mol Genet 14: 2349-2356.
19. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M et al. (2000). N Engl J Med 343: 78-85.
20. Newton MA, Lee Y. (2000). Biometrics 56: 1088-1097.
21. Nikitin AYu, Ballering LA, Lyons J, Rajewsky MF. (1991). Proc Natl Acad Sci USA 88: 9939-9943.
22. Norlander C, Behboudi A, Levan G, Levan KK. (2005). Cancer Genet Cytogenet 156: 158-166.
23. Okimoto K, Sakurai J, Kobayashi T, Mitani H, Hirayama Y, Nickerson ML et al. (2004). Proc Natl Acad Sci USA 101: 2023-2027.
24. Peto J. (2000). N Engl J Med 343: 1495-1496.
25. Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI et al. (1998). Cancer Res 58: 1004-1012.
26. Ponder BAJ, Cebrian A, Dunning AM, Easton DF, Lesueur F, Luccarini C et al. (2005). Breast Cancer Res 7(Suppl 2): S.40.
27. Samuelson DJ, Aperavich BA, Haag JD, Gould MN. (2005). Cancer Res 65: 9637-9642.
28. Samuelson DJ, Haag JD, Lan H, Monson DM, Shultz MA, Kolman BD et al. (2003). Carcinogenesis 24: 1445-1460.
29. Shepel LA, Lan H, Haag JD, Brasic GM, Gheen ME, Simon JS et al. (1998). Genetics 149: 289-299.
30. Thompson D, Easton D. (2004). J Mammary Gland Biol Neopl 9: 221-236.
31. Toyota M, Ushijima T, Weisburger JH, Hosoya Y, Canzian F, Rivenson A et al. (1996). Mol Carcinog 15: 176-182.
32. Yu M, Ryu DY, Snyderwine EG. (2000). Mol Carcinog 27: 76-83.